Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

Sherene S. Min; Amanda H. Corbett; Naser Rezk; Susan Cu-Uvin; Susan A. Fiscus; Leslie Petch; Myron S. Cohen; Angela D.M. Kashuba

doi:10.1097/00126334-200412150-00008

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

Sherene S. Min, Amanda H. Corbett, Naser Rezk, Susan Cu-Uvin, Susan A. Fiscus, Leslie Petch, Myron S. Cohen, Angela D.M. Kashuba

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

The pharmacokinetics of antiretrovirals (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and post-exposure prophylaxis regimens. This study is the first to compare ARV concentrations in direct aspirates of cervicovaginal fluid (CVF) and blood plasma (BP). This unique method provides direct assessment of concentrations without the confounding of cervicovaginal lavage dilution. Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary.

Original language	English (US)
Pages (from-to)	1577-1580
Number of pages	4
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	37
Issue number	5
DOIs	https://doi.org/10.1097/00126334-200412150-00008
State	Published - Dec 15 2004
Externally published	Yes

Keywords

Antiretroviral concentration
Female genital tract
HIV-1
Nonnucleoside reverse transcriptase inhibitor
Pharmacokinetic
Protease inhibitor

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00126334-200412150-00008

Cite this

@article{40a4e8d188d44f50b9bd59b48729f6f3,

title = "Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women",

abstract = "The pharmacokinetics of antiretrovirals (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and post-exposure prophylaxis regimens. This study is the first to compare ARV concentrations in direct aspirates of cervicovaginal fluid (CVF) and blood plasma (BP). This unique method provides direct assessment of concentrations without the confounding of cervicovaginal lavage dilution. Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary.",

keywords = "Antiretroviral concentration, Female genital tract, HIV-1, Nonnucleoside reverse transcriptase inhibitor, Pharmacokinetic, Protease inhibitor",

author = "Min, {Sherene S.} and Corbett, {Amanda H.} and Naser Rezk and Susan Cu-Uvin and Fiscus, {Susan A.} and Leslie Petch and Cohen, {Myron S.} and Kashuba, {Angela D.M.}",

year = "2004",

month = dec,

day = "15",

doi = "10.1097/00126334-200412150-00008",

language = "English (US)",

volume = "37",

pages = "1577--1580",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

AU - Min, Sherene S.

AU - Corbett, Amanda H.

AU - Rezk, Naser

AU - Cu-Uvin, Susan

AU - Fiscus, Susan A.

AU - Petch, Leslie

AU - Cohen, Myron S.

AU - Kashuba, Angela D.M.

PY - 2004/12/15

Y1 - 2004/12/15

N2 - The pharmacokinetics of antiretrovirals (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and post-exposure prophylaxis regimens. This study is the first to compare ARV concentrations in direct aspirates of cervicovaginal fluid (CVF) and blood plasma (BP). This unique method provides direct assessment of concentrations without the confounding of cervicovaginal lavage dilution. Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary.

AB - The pharmacokinetics of antiretrovirals (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and post-exposure prophylaxis regimens. This study is the first to compare ARV concentrations in direct aspirates of cervicovaginal fluid (CVF) and blood plasma (BP). This unique method provides direct assessment of concentrations without the confounding of cervicovaginal lavage dilution. Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary.

KW - Antiretroviral concentration

KW - Female genital tract

KW - HIV-1

KW - Nonnucleoside reverse transcriptase inhibitor

KW - Pharmacokinetic

KW - Protease inhibitor

UR - http://www.scopus.com/inward/record.url?scp=10644295700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10644295700&partnerID=8YFLogxK

U2 - 10.1097/00126334-200412150-00008

DO - 10.1097/00126334-200412150-00008

M3 - Article

C2 - 15577412

AN - SCOPUS:10644295700

SN - 1525-4135

VL - 37

SP - 1577

EP - 1580

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 5

ER -

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this